246 related articles for article (PubMed ID: 26993858)
1. Novel interferonopathies associated with mutations in RIG-I like receptors.
Buers I; Nitschke Y; Rutsch F
Cytokine Growth Factor Rev; 2016 Jun; 29():101-7. PubMed ID: 26993858
[TBL] [Abstract][Full Text] [Related]
2. RIG-I-Like Receptors and Type I Interferonopathies.
Kato H; Oh SW; Fujita T
J Interferon Cytokine Res; 2017 May; 37(5):207-213. PubMed ID: 28475461
[TBL] [Abstract][Full Text] [Related]
3. MDA5-Associated Neuroinflammation and the Singleton-Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum.
Buers I; Rice GI; Crow YJ; Rutsch F
J Interferon Cytokine Res; 2017 May; 37(5):214-219. PubMed ID: 28475458
[TBL] [Abstract][Full Text] [Related]
4. RIG-I-like receptors and autoimmune diseases.
Kato H; Fujita T
Curr Opin Immunol; 2015 Dec; 37():40-5. PubMed ID: 26530735
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
[TBL] [Abstract][Full Text] [Related]
6. Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation.
He FB; Khan H; Huttunen M; Kolehmainen P; Melén K; Maljanen S; Qu M; Jiang M; Kakkola L; Julkunen I
Front Immunol; 2021; 12():694105. PubMed ID: 35069519
[TBL] [Abstract][Full Text] [Related]
7. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
8. ZFYVE1 negatively regulates MDA5- but not RIG-I-mediated innate antiviral response.
Zhong X; Feng L; Zang R; Lei CQ; Yang Q; Shu HB
PLoS Pathog; 2020 Apr; 16(4):e1008457. PubMed ID: 32251420
[TBL] [Abstract][Full Text] [Related]
9. Computational Insights into the Structural Dynamics of MDA5 Variants Associated with Aicardi-Goutières Syndrome and Singleton-Merten Syndrome.
Gosu V; Sasidharan S; Saudagar P; Lee HK; Shin D
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439917
[TBL] [Abstract][Full Text] [Related]
10. Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Goutières and Singleton-Merten syndromes.
Bursztejn AC; Briggs TA; del Toro Duany Y; Anderson BH; O'Sullivan J; Williams SG; Bodemer C; Fraitag S; Gebhard F; Leheup B; Lemelle I; Oojageer A; Raffo E; Schmitt E; Rice GI; Hur S; Crow YJ
Br J Dermatol; 2015 Dec; 173(6):1505-13. PubMed ID: 26284909
[TBL] [Abstract][Full Text] [Related]
11. RIG-I-Like Receptors: One STrEP Forward.
Lässig C; Hopfner KP
Trends Microbiol; 2016 Jul; 24(7):517-519. PubMed ID: 27236860
[TBL] [Abstract][Full Text] [Related]
12. Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5.
Brisse M; Ly H
Front Immunol; 2019; 10():1586. PubMed ID: 31379819
[TBL] [Abstract][Full Text] [Related]
13. HDX-MS reveals dysregulated checkpoints that compromise discrimination against self RNA during RIG-I mediated autoimmunity.
Zheng J; Wang C; Chang MR; Devarkar SC; Schweibenz B; Crynen GC; Garcia-Ordonez RD; Pascal BD; Novick SJ; Patel SS; Marcotrigiano J; Griffin PR
Nat Commun; 2018 Dec; 9(1):5366. PubMed ID: 30560918
[TBL] [Abstract][Full Text] [Related]
14. Genetic interferonopathies: An overview.
Eleftheriou D; Brogan PA
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
[TBL] [Abstract][Full Text] [Related]
15. Unique O-methoxyethyl ribose-DNA chimeric oligonucleotide induces an atypical melanoma differentiation-associated gene 5-dependent induction of type I interferon response.
Burel SA; Machemer T; Ragone FL; Kato H; Cauntay P; Greenlee S; Salim A; Gaarde WA; Hung G; Peralta R; Freier SM; Henry SP
J Pharmacol Exp Ther; 2012 Jul; 342(1):150-62. PubMed ID: 22505629
[TBL] [Abstract][Full Text] [Related]
16. [Type I interferonopathies].
Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
[TBL] [Abstract][Full Text] [Related]
17. Murine norovirus replicase augments RIG-I-like receptors-mediated antiviral interferon response.
Yu P; Li Y; Li Y; Miao Z; Wang Y; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Oct; 182():104877. PubMed ID: 32755662
[TBL] [Abstract][Full Text] [Related]
18. [Recognition of viral nucleic acids and regulation of type I IFN expression].
Onomoto K; Yoneyama M; Fujita T
Nihon Rinsho; 2006 Jul; 64(7):1236-43. PubMed ID: 16838638
[TBL] [Abstract][Full Text] [Related]
19. RIG-I-Like Receptor Signaling in Singleton-Merten Syndrome.
Lu C; MacDougall M
Front Genet; 2017; 8():118. PubMed ID: 28955379
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile after activation of RIG-I in 5'ppp-dsRNA challenged DF1.
Chen Y; Xu Q; Li Y; Liu R; Huang Z; Wang B; Chen G
Dev Comp Immunol; 2016 Dec; 65():191-200. PubMed ID: 27450445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
